Metabolism
Metabolism inhibitors are compounds that interfere with metabolic pathways, altering the production and utilization of energy within cells. These inhibitors are used to study the regulation of metabolism, the role of metabolic pathways in diseases like cancer and diabetes, and to develop new therapeutic strategies. Metabolism inhibitors can target various enzymes and processes involved in glycolysis, fatty acid oxidation, and other metabolic functions. At CymitQuimica, we offer a wide range of high-quality metabolism inhibitors to support your research in biochemistry, metabolic disorders, and drug development.
Subcategories of "Metabolism"
- AhR(42 products)
- Aminopeptidase(76 products)
- CETP(20 products)
- Carbonic Anhydrase(196 products)
- Casein Kinase(138 products)
- DHFR(29 products)
- Decarboxylase(4 products)
- Dehydrogenase(300 products)
- FAAH(64 products)
- FXR(62 products)
- Factor Xa(87 products)
- Fatty Acid Synthase(37 products)
- Ferroptosis(226 products)
- GR(3 products)
- GSNOR(3 products)
- Glucokinase(56 products)
- HIF/HIF Prolyl-Hydroxylase(146 products)
- HMG-CoA Reductase(34 products)
- Hydroxylase(36 products)
- IDO(84 products)
- LDL(7 products)
- Lipase(107 products)
- Lipid(62 products)
- Lipoxygenase(133 products)
- MAO(86 products)
- MPO(2 products)
- NAMPT(40 products)
- P450(6 products)
- PAI-1(26 products)
- PDE(169 products)
- PED(1 products)
- PKM(17 products)
- PPAR(170 products)
- Phospholipase(85 products)
- ROR(47 products)
- Retinoid Receptor(20 products)
- SGK(10 products)
- Thioredoxin(12 products)
- Transferase(29 products)
- Transporter(44 products)
- UGT(4 products)
- Xanthine Oxidase (XO) Inhibitors(9 products)
Show 34 more subcategories
Found 9204 products of "Metabolism"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Etoricoxib N1'-oxide
CAS:EtoricoxibN1'-oxide is a metabolite of Etoricoxib. It does not inhibit COX-1 and does not significantly inhibit COX-2.Formula:C18H15ClN2O3SColor and Shape:SolidMolecular weight:374.841Implitapide
CAS:Implitapide is an inhibitor of microsomal triglyceride transfer protein (MTP).Formula:C35H37N3O2Purity:98%Color and Shape:SolidMolecular weight:531.69Anticancer agent 143
CAS:Anticancer Agent 143 (Compound 369), a potent dual inhibitor targeting PTPN2 and PTP1B, exhibits IC50 values below 2.5 nM.Formula:C19H15BrF2N3O6PS2Purity:98%Color and Shape:SolidMolecular weight:594.34PDEδ-IN-1
CAS:PDEδ-IN-1 is a ligand for PDEδ and can be utilized in the synthesis of PDEδ autophagic degrader 1.Formula:C18H20N4O3Color and Shape:SolidMolecular weight:340.38Asimicin
CAS:Asimicin is a effective complex I inhibitor.Formula:C37H66O7Purity:98%Color and Shape:SolidMolecular weight:622.92GK420
CAS:GK420 (AVX420) is a potent inhibitor of cytoplasmic phospholipase A2α (cPLA2α), with an XI(50) value of 0.0016. It effectively inhibits the release of arachidonic acid, with an EC50 of 0.09 μM. GK420 plays a significant role in cancer research.Formula:C20H25NO5SColor and Shape:SolidMolecular weight:391.481TAK-828F
CAS:TAK-828F: potent, selective RORγt inverse agonist. Oral. IC50=1.9 nM; reporter gene IC50=6.1 nM.Formula:C28H32FN3O5Purity:98%Color and Shape:SolidMolecular weight:509.57(±)14(15)-DiHETE
CAS:(±)14(15)-DiHETE is an oxidized lipid and a metabolite of Eicosapentaenoic Acid, which is an orally active Omega-3 long-chain polyunsaturated fatty acid (ω-3 LC-PUFA).Formula:C20H32O4Color and Shape:SolidMolecular weight:336.47Keto lovastatin
CAS:Keto lovastatin is an impurity of lovastatin with antibacterial properties. Lovastatin is a cell-permeable HMG-CoA reductase (HMG-CoA reductase) inhibitor used to reduce cholesterol levels.Formula:C24H34O6Color and Shape:SolidMolecular weight:418.523JTZ-951 HCl
CAS:JTZ-951 is a potent and orally active inhibitor of hypoxia inducible factor prolyl hydroxylase (PHD).Formula:C17H17ClN4O4Purity:98%Color and Shape:SolidMolecular weight:376.79Zolpyridine
CAS:Zolpyridine is a degradation product of Zolpidem tartrate.Formula:C14H14N2OColor and Shape:SolidMolecular weight:226.27ALOX15-IN-1
ALOX15-IN-1 (8b) inhibits rabbit/human ALOX15; IC50: 0.04 μM for LA, 2.06 μM for AA.Formula:C24H31N3O5SColor and Shape:SolidMolecular weight:473.59HIF-2α-IN-5
CAS:HIF-2α-IN-5 is a potent HIF-2α inhibitor with an IC 50 of < 50 nM [1].Formula:C15H12F4O3S2Color and Shape:SolidMolecular weight:380.38Xanthosine-5'-monophosphate
CAS:Xanthosine 5'-monophosphate is produced from inosine monophosphate (IMP) through the catalytic action of inosine monophosphate dehydrogenase (IMPDH).Formula:C10H13N4O9PColor and Shape:SolidMolecular weight:364.21α-Glucosidase-IN-19
Alpha-Glucosidase-IN-19 (Compound 6B) is an orally active alpha-glucosidase inhibitor (IC50: 3.63 μM) with antidiabetic effects.Formula:C31H25NOSColor and Shape:SolidMolecular weight:459.6CK1δ-IN-3
CAS:CK1δ-IN-3 (compound 376) is a CK1δ (casein kinase 1δ) inhibitor that can be used to study neurodegenerative diseases such as Alzheimer's disease.Formula:C24H19N3O2SPurity:99.27%Color and Shape:SolidMolecular weight:413.49Z57346765
CAS:Z57346765 is a specific PGK1 inhibitor that inhibits PGK1-dependent cell proliferation by decreasing the metabolic enzyme activity of PGK1 during glycolysis.Formula:C17H18N4OPurity:99.85%Color and Shape:SolidMolecular weight:294.35Enpp-1-IN-12
ENPP1-IN-12 is a potent, oral ENPP1 inhibitor with a Ki of 41 nM and anti-tumor properties.Formula:C17H19N5O3SColor and Shape:SolidMolecular weight:373.43Casein kinase 1δ-IN-25
CAS:Casein kinase1δ-IN-25 (compound 487) is a potent inhibitor of casein kinase1δ. It is applicable in research on neurodegenerative diseases such as Alzheimer's disease.Formula:C20H14FN3O4S2Color and Shape:SolidMolecular weight:443.471PRL3-CNNM4 interaction-IN-1
CAS:PRL3-CNNM4 interaction-IN-1 (Compound C28d52) is an inhibitor of the PRL3-CNNM4 interaction that also suppresses CNNM inhibition mediated by PRL. This compound exhibits favorable pharmacokinetic and drug metabolism properties.Formula:C8H8O2SColor and Shape:SolidMolecular weight:168.21
